San Francisco Examiner25d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ... Approval of Spravato, granted ...
Hosted on MSN24d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Approval of Spravato, granted following FDA priority review, was based on the results ... 7.6 percent of patients taking placebo. Spravato nasal spray is administered by the patient under the ...
Medical Xpress25d
FDA approves nasal spray for treatment-resistant depression
Approval of Spravato, granted following FDA priority review, was based on the results ... compared with 7.6% of patients taking placebo. Spravato nasal spray is administered by the patient under ...
mic25d
A Nasal Spray For Depression? FDA Gives Its Approval
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato ... The FDA's approval of Spravato followed a priority review process based on extensive clinical ...
Wyoming News25d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults ... FDA priority review, was based on the results ...